Explore how Shire and Santaris' LNA platform is transforming rare disease treatment through innovative genetic technology.
Explore recent advances in genetic therapy for hepatitis B virus, including CRISPR, TALENs, and ARCUS technologies that target HBV DNA for potential cure.